Rasionalitas penggunaan obat pada pasien PPOK di Puskesmas XYZ Jakarta
DOI:
https://doi.org/10.32504/hspj.v6i2.672Keywords:
Drugs, Chronic Obstructive Pulmonary Disease, rationalityAbstract
Chronic Obstructive Pulmonary Disease (COPD) is a chronic pulmonary disease characterized by the occurrence of obstruction or obstruction of air flow in the airway that is progressively non reversible or partially reversible. An evaluation study of drug use in chronic obstructive pulmonary disease patients has been conducted at the XYZ Jakarta Health Center for the period of July – December 2017. The purpose of this study is to find out the pattern of drug use and the suitability of COPD treatment in adult patients at the Outpatient Installation of Public Health center XYZ Jakarta for the period of January-June 2017 which includes gender and comorbidity. The research was carried out at the Outpatient Installation of Public Health center XYZ Jakarta in November-December 2017 with a research method using descriptive by looking at the medical record data of adult COPD patients with a retrospective method, and sampling was carried out using the purposive sampling method for the January-June 2017 period. The results of the study at Public Health center XYZ Jakarta on patients with Chronic Obstructive Pulmonary Disease of which out of 115 people the most widely used use of COPD drugs in patients that were most widely used was Beta Agonist 2 with the drug name Salbutamol as many as 112 (26.05%) items and the most widely used dosage form was the tablet dosage form, which was 381 (89.23%). The severity of the use of COPD drugs in adult patients was based on the criteria of appropriate indications (99.64%), appropriate drugs (99.64%), and appropriate dosage (100%). The conclusion in this study was that the rationality of drugs use in COPD patients has still 0.36% irrational use in indications and drugs.
References
Perhimpunan Dokter Paru Indonesia. Penyakit Paru Obstruktif Kronik (PPOK). Pedoman Diagnosis & Penatalaksanaan di Indonesia. Jakarta: Perhimpunan Dokter Paru Indonesia; 2003. 1–57 p.
Currie GP. Chronic Obstructive Pulmonary Disease. New York: Oxford University Press Inc.; 2009.
Global Initiative for Chronic Obstructive Lung Disease Inc. Pocket Guide To Copd Diagnosis, Management, And Prevention A Guide for Health Care Professionals [Internet]. 2017. Available from: www.goldcopd.org
World Health Organization. Chronic Obstructive Pulmonary Disease (COPD) [Internet]. World Health Organization. 2022 [cited 2022 Aug 25]. Available from:
https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
Departemen Kesehatan Ditjen P2 & PL Dit Pengendalian Penyakit tidak Menular. Pedoman pengendalian penyakit paru obstruktif kronik (PPOK). 2010.
Kementerian Kesehatan RI. Riset Kesehatan Dasar (RISKESDAS 2013). Jakarta; 2013 Dec.
The National Collaborating Centrefor Chronic Conditions. Chronic Obstructive Pulmonary Disease [Internet]. Thorax. London: BMJ Publisihing Group; 2004. 1–18 p. Available from:
http://thorax.bmj.com/cgi/doi/10.1136/thx.2004.022707
Han MK, Lazarus SC. COPD: Clinical Diagnosis and Management. In: Textbook of Respiratory Medicine. 6th Edition. Vancouver: Elsevier Inc.; 2016.
Sumantri S. Pendekatan Diagnostik Hipokalemia. Jakarta: Departemen Ilmu Penyakit Dalam FKUI; 2009.
Williams DM, Bourdet S v. Chronic Obstructive Pulmonary Disease. In: Pharmacotherapy : A Pathophysiologic Approach. seventh edition. New York: Mc Graw-Hill; 2014. p. 528–50.
Ikawati Z. Farmakoterapi Penyakit Sistem Pernafasan. Yogyakarta: UGM Press; 2006.
Fasitasari M. Terapi Gizi pada Lanjut Usia dengan Penyakit Paru Obstruktif Kronik (PPOK) Nutrition Therapy in Elderly with Chronic Obstructive Pulmonary Disease (COPD). Vol. 5, Sains Medika. 2013.
Adil MS, Amer Khan M, Nematullah Khan M, Sultan I, Aamer Khan M, Amir Ali S, et al. EMPADE study: Evaluation of medical prescriptions and adverse drug events in COPD patients admitted to intensive care unit. Journal of Clinical and Diagnostic Research. 2015 Nov 1;9(11):FC05–8.
Oemiati R. Kajian Epidemiologis Penyakit Paru Obstruktif Kronik (PPOK) Epidemiologic Study Of Chronic Obstructive Pulmonary Disease (COPD). Media Litbangkes. 2013; 23(2):82–8.
İliaz S, İliaz R, Börekçi Ş, Atik Güngör S, Uğur Chousein EG, Tural Onur S, et al. The awareness of chest physicians about nutritional assessment in chronic obstructive pulmonary disease. Tuberk Toraks. 2016;64(1):41–6.
Arroyo JP, Schweickert AJ. Back to Basics in Physiology :O2 and CO2 in the Respiratory and Cardiovascular Systems. Oxford : Academic Press and Elsevier Inc.; 2015. 22–64 p.
Ganong WF. Review of Medical Physiology. Ed. 22nd. New York: MCR Vision, Inc; 2005.
Prendergast TJ, Ruoss SJ. Pulmonary Disease. In : SJ. McPhee and W.F. Ganong. Eds. Pathophysiology of Disease : An Introduction to Clinical Medicine. In: 5th Edition. New York: McGraw-Hill Companies, Inc.; 2005.
